AIM
CCXI

Acrospire Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Acrospire Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,504
Closed -$42K – 1625
2017
Q2 		$42K Sell
4,504
-1,445
-24% -$10.6K 0.04% 1029
2017
Q1 		$43K Sell
5,949
-26,340
-82% -$190K 0.04% 1086
2016
Q4 		$239K Buy
32,289
+1,249
+4% +$8.99K 0.1% 248
2016
Q3 		$187K Buy
31,040
+20,441
+193% +$96.6K 0.12% 189
2016
Q2 		$48K Buy
+10,599
New +$39.8K 0.04% 1094

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acrospire Investment Management's CCXI Position: Q3 2017 in Review

Acrospire Investment Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2017, closing a stake of 4,504 shares — an estimated $42K sold.

Acrospire Investment Management first reported a position in CCXI in Q2 2016 and held it in 5 quarters. The position peaked at $239K in Q4 2016. 86 funds tracked by Wall St. Rank hold CCXI as of Q3 2017.

  • Acrospire Investment Management reported no remaining ChemoCentryx, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 4,504 ChemoCentryx, Inc. shares in Q3 2017, an estimated $42K.
  • Acrospire Investment Management first reported a position in ChemoCentryx, Inc. in Q2 2016 and held it in 5 quarters.
  • Acrospire Investment Management's ChemoCentryx, Inc. position peaked at $239K in Q4 2016.
  • 86 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.